Migliarese Antonio 4
4 · CytoDyn Inc. · Filed Nov 30, 2022
Insider Transaction Report
Form 4
CytoDyn Inc.CYDY
Migliarese Antonio
Chief Financial Officer
Transactions
- Award
Non-qualified stock option (right to buy)
2022-11-28+4,585,536→ 4,585,536 totalExercise: $0.35Exp: 2032-11-28→ Common Stock (4,585,536 underlying) - Award
Common Stock
2022-11-30+12,008→ 183,207 total
Footnotes (2)
- [F1]Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary.
- [F2]477,660 shares vested on November 28, 2022; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from November 2022 through May 2026.